Very very happy.
Another step, another box ticked in the company's march towards a Phase 1 trial, which if successful, (and if precedent holds) should see us valued around the $150 - $200 million mark.
Every company is different and that valuation is only based on my long history investing in and studying medical companies. Obviously depends on the sentiment of the market as a whole.... anyway, we will see what happens! Although today's announcement very very positive.
Bring on the Phase 1 next quarter!
Ann: Maximum Tolerated Dose Successfully Established in Studies, page-3
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
78.5¢ |
Change
-0.015(1.88%) |
Mkt cap ! $99.79M | |||
| Open | High | Low | Value | Volume |
| 81.0¢ | 81.0¢ | 78.5¢ | $26.08K | 32.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10299 | 78.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 6713 | 1 |
View Market Depth
| Last trade - 15.53pm 04/09/2024 (20 minute delay) ? |
| AGN (ASX) Chart |